Abstract 6858: The next generation transcriptional inhibitor PM54 demonstrates strong antitumor activity in patient-derived xenograft models of soft tissue sarcoma
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: KU Leuven, PharmaMar (Spain), Universitair Ziekenhuis Leuven
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630896
